Antares Pharma (ATRS) announced Chief Financial Officer James Fickenscher has informed the company that he will resign effective September 4 to pursue other interests. VP, Finance and Corporate Controller Keith Muckenhim will serve as interim CFO, principal accounting officer and principal financial officer while the company completes its search for a permanent CFO.